Thomas Weber

Thomas Weber

Hogan Lovells

Contact
View Bio
RSS

Latest Posts › EU

Share:

Life Sciences Law Update Key developments for pharma and medical device companies in EU and Germany, France, UK, Italy and Spain...

Pharma: Reform of the EU Pharmaceutical Legislation; German Medical Research Act enacted fostering R&D also including confidentiality of drug prices; France adopts standard CTA clauses; UK easing clinical trials; Devices:...more

7/21/2025  /  Clinical Trials , Competition , Corporate Governance , Data Privacy , EU , Germany , Medical Devices , Popular , Regulatory Requirements , UK

Life Sciences Law Update - Key developments for pharma and medical device companies in EU and Germany, France, UK, Italy and Spain...

Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need to revise the MDR and IVDR published; Compliance: CSRD still not implemented in...more

1/22/2025  /  Artificial Intelligence , Clinical Trials , Competition , Cybersecurity , Data Privacy , EU , European Medicines Agency (EMA) , Life Sciences , Medical Devices , Pharmaceutical Industry

Public Takeovers in Germany

Welcome to the fourth edition of our “Public Takeovers in Germany” newsletter. It provides an overview of public takeovers carried out in Germany in 2020 under the German Securities Acquisition and Takeover Act (WpÜG) and of...more

3/15/2021  /  Acquisition Agreements , Corporate Sales Transactions , Critical Infrastructure Sectors , Delisting , EU , Germany , Merger Agreements , Publicly-Traded Companies , Takeovers
3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide